Evidence map›Paper›PMID 41304544›Full record

ArticleToxics2025

Potential Toxicological Risk Associated with the Oral Use of Colloidal Silver Dietary Supplements.

Oana Catalina Bute, Anca-Irina Gheboianu, Bogdan Trica, Ana-Maria Hossu

Abstract read
In one paragraph

Article in Toxics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Oana Catalina ButeFaculty of Sciences and Arts, Valahia University of Târgoviște, 13 Sinaia Alley, 130004 Târgoviște, Romania.
Anca-Irina GheboianuInstitute of Multidisciplinary Research for Science and Technology, Valahia University of Târgoviște, 13 Sinaia Alley, 130004 Târgoviște, Romania.ORCID 0000-0001-5380-4553
Bogdan TricaNational Institute for Research & Development in Chemistry and Petrochemistry-ICECHIM Bucharest, 202 Splaiul Independentei, 060021 Bucharest, Romania.ORCID 0000-0002-9948-6914
Ana-Maria HossuFaculty of Sciences and Arts, Valahia University of Târgoviște, 13 Sinaia Alley, 130004 Târgoviște, Romania.

Funding

Romanian Ministry of Education and Research, National Authority for Scientific Research (ANC), Nucleu Programme ChemNewDeal, project PN 23.06.02.01-InteGral
6 · The paper itself

Abstract

The increasing availability of colloidal silver dietary supplements raises important concerns regarding their safety when used for oral consumption. This study presents the physicochemical characterization of a commercial colloidal silver solution with a high concentration (1000 mg/L), stabilized with pectin in distilled water. The characterization was performed using UV-VIS, XRD, and TEM. The manufacturer did not provide information regarding nanoparticle size or recommended duration of use. The 1000 mg/L sample was also compared with a standard colloidal silver solution provided by Sigma Aldrich to validate nanoparticle size, stability, and spectral profiles. In addition, a comparative theoretical analysis was conducted on other commercially available products containing colloidal silver at concentrations of 15, 30, 55, 80, and 125 mg/L, based solely on the recommended daily intake and the oral reference dose of 0.005 mg/kg/day established by the United States Environmental Protection Agency (EPA). Although no in vivo or in vitro toxicity tests were performed, the results indicate a potential toxicological risk due to estimated intake levels that may exceed safety thresholds, particularly in high-concentration products with insufficient labelling or unclear usage guidelines. These findings emphasize the need for stricter regulatory measures and greater public awareness regarding the internal use of colloidal silver supplements.

Indexed as

colloidal silverdietary supplementsestimated toxicological risknanoparticlesoral exposure

Identifiers

PMID41304544
PMCPMC12656528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.